Thomas Geisbert
Overview
Explore the profile of Thomas Geisbert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pinski A, Woolsey C, Jankeel A, Cross R, Basler C, Geisbert T, et al.
J Virol
. 2021 Jan;
95(6).
PMID: 33408171
Infection with (EBOV), a member of the family, causes a disease characterized by high levels of viremia, aberrant inflammation, coagulopathy, and lymphopenia. EBOV initially replicates in lymphoid tissues and disseminates...
2.
Safronetz D, Mire C, Rosenke K, Feldmann F, Haddock E, Geisbert T, et al.
PLoS Negl Trop Dis
. 2015 Apr;
9(4):e0003736.
PMID: 25884628
Background: Lassa virus (LASV) is endemic in several West African countries and is the etiological agent of Lassa fever. Despite the high annual incidence and significant morbidity and mortality rates,...
3.
Feldmann H, Geisbert T, Kawaoka Y
J Infect Dis
. 2007 Dec;
196 Suppl 2:S129-30.
PMID: 17940939
No abstract available.
4.
Feldmann H, Jones S, Schnittler H, Geisbert T
Curr Opin Investig Drugs
. 2005 Aug;
6(8):823-30.
PMID: 16121689
The first cases of Ebola hemorrhagic fever were reported from Sudan and Zaire (now Democratic Republic of the Congo) in 1976, but the virus has only received significant attention since...
5.
Liang M, Geisbert T, Yao Y, Hinrichs S, Giam C
J Virol
. 2002 Mar;
76(8):4022-33.
PMID: 11907241
Human T-lymphotropic virus type 1 (HTLV-1) Tax exerts pleiotropic effects on multiple cellular regulatory processes to bring about NF-kappaB activation, aberrant cell cycle progression, and cell transformation. Here we report...